As per MRFR analysis, the South Korea Nano Biotechnology Market Size was estimated at 111.68 (USD Million) in 2023.The South Korea Nano Biotechnology Market is expected to grow from 122.4(USD Million) in 2024 to 303.6 (USD Million) by 2035. The South Korea Nano Biotechnology Market CAGR (growth rate) is expected to be around 8.609% during the forecast period (2025 - 2035).
Key South Korea Nano Biotechnology Market Trends Highlighted
The growing need for cutting-edge medical treatments and agricultural innovation have propelled notable market trends in South Korea's nano biotechnology sector. The South Korean government has demonstrated a strong commitment to biotechnology as a major national agenda item and has provided considerable support for research and development in this area.
South Korea is becoming a pioneer in DNA nanotechnology and nanomedicine thanks to substantial government funding and initiatives that have accelerated these fields' development. As a result, South Korean companies are using nanotechnology in diagnostics and drug delivery, improving the effectiveness and efficiency of healthcare.
Additionally, the emergence of personalised medicine is opening doors for the creation of nanoparticles that can target particular illnesses, allowing for the customisation of treatments to meet the needs of each patient. This change is in line with South Korea's strong healthcare system and emphasis on incorporating technology into clinical procedures.
Current patterns show that industry participants and academic institutions are working together more frequently, which promotes innovation and speeds up the commercialisation of products utilising nanobiotechnology. Additionally, the agricultural industry is expanding significantly, with farmers seeking sustainable farming solutions increasingly turning to nanopesticides and fertilisers.
Urban agriculture investigates these nano uses to improve crop productivity and safety, especially in urban settings like Seoul. South Korea has a chance to use its cutting-edge research capabilities to offer more environmentally friendly and effective solutions as consumer awareness of health and environmental issues grows.
Overall, there are many opportunities for growth and development in the South Korean nano biotechnology market, which is characterised by dynamic trends supported by institutional backing and emerging technological developments.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South Korea Nano Biotechnology Market Drivers
Increasing Focus on Healthcare Innovations
The South Korea Nano Biotechnology Market is experiencing significant growth due to the country's increasing focus on healthcare innovations. South Korea has invested heavily in Research and Development (R&D), allocating approximately 4.2% of its Gross Domestic Product (GDP) to R&D expenditures, one of the highest rates globally.
This investment is expected to foster advancements in nanotechnology applications in biomedicine, leading to the development of novel therapeutic solutions.
The Ministry of Science and ICT has also announced plans to enhance support for nano-biotechnology research, which involves collaborations with notable institutions like POSTECH and KAIST. Such initiatives are likely to drive the adoption of innovative nanobiotech solutions in various healthcare sectors, fueling market growth in South Korea.
Growing Incidence of Chronic Diseases
The rise in chronic diseases, particularly cancer and diabetes, is significantly impacting the South Korea Nano Biotechnology Market. Recent statistics show that cancer has become one of the leading causes of death in South Korea, with the Korean National Cancer Center reporting an increase in cancer incidence by approximately 11.7% over the past five years.
This growing need for effective diagnosis and treatment options significantly propels demand for nano-biotechnology products that can enable early detection and targeted therapies. Companies like LG Chem and Samsung Biologics are heavily investing in nanotechnology to develop innovative therapeutic solutions to address this pressing healthcare issue.
Supportive Government Policies and Regulations
Government support plays a pivotal role in the growth of the South Korea Nano Biotechnology Market. Recently, the South Korean government unveiled its 'Bio-Health Industry Strategy', aiming to expand the country's biopharmaceutical sector and promote nano-biotechnology research. The strategy includes financial support and incentives for biotech firms that engage in innovative R&D and products.
With the aim to enhance global competitiveness, this initiative is likely to stimulate collaboration between academia, industry, and government agencies, creating a conducive environment for nano-biotechnology innovations. This backing from the government positions South Korea as a leading player in the nano-biotech landscape.
Rising Investment from Private Sector
The South Korea Nano Biotechnology Market is witnessing increased investments from private enterprises, which are essential for driving innovation. In recent years, private sector investment in biotechnology has surged, with companies such as Hanmi Pharmaceutical and SK Bioscience actively pursuing nanobiotechnology ventures.
This trend is fueled by the potential returns on investment offered by groundbreaking nanotechnology solutions in pharmaceuticals and diagnostics.
The Ministry of Health and Welfare has noted that private investments in the biomedical sector are expected to grow by 20% annually over the next five years. Such interest from the private sector enhances the prospects for the South Korea Nano Biotechnology Market, allowing for greater R&D capabilities and faster product commercialization.
South Korea Nano Biotechnology Market Segment Insights
Nano Biotechnology Market Application Insights
The South Korea Nano Biotechnology Market, particularly in the Application segment, presents a robust landscape characterized by its diverse applications across various fields.
The market is gaining momentum from the increasing adoption of nanotechnology in Pharmaceuticals, where the focus is on decreasing drug delivery time while enhancing therapeutic outcomes through targeted and controlled release systems.
This segment demonstrates significant advancements in drug formulation, which have revolutionized the way pharmaceuticals are developed and delivered, ultimately improving patient compliance and treatment efficacy. In the domain of Medical devices, the integration of nanotechnology allows for the creation of more efficient and effective imaging devices, diagnostic tools, and therapeutic equipment.
The use of nanomaterials can significantly enhance device performance, leading to better patient outcomes and opening avenues for the development of devices that are less invasive and provide high accuracy in diagnostics.
The Medical research segment is also thriving as numerous research institutions in South Korea invest in nanobiotechnology to better understand diseases at the molecular level. This segment is fundamental for fostering innovation in treatment methods and contributes to the overall advancement of the healthcare sector.
Furthermore, in the Food and Agriculture sector, nanotechnology holds promise in areas such as food safety and agriculture efficiency. The techniques derived from nanotechnology can improve material properties, enhance nutrient delivery for crops, and ensure better packaging that extends shelf life while maintaining food safety and quality.
South Korea's commitment to enhancing food security through advanced agricultural practices makes this application a critical area of growth. The South Korea Nano Biotechnology Market is characterized by dynamic interplay among these applications, driven by increasing investments in Research and Development (R&D) and government-funded initiatives aimed at bolstering innovation.
These growth drivers reflect the critical role of nanotechnology in addressing current global challenges, including healthcare efficiency, food safety, and resource sustainability. While opportunities abound, challenges remain concerning regulatory frameworks and public perception of nanotechnology applications, particularly in health-related sectors.
Nevertheless, with the nation's strong emphasis on technological advancement and national health initiatives, the future of the South Korea Nano Biotechnology Market in the Application segment looks promising, as it continuously evolves and adjusts to meet both industry standards and consumer needs.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Nano Biotechnology Market Therapeutics Insights
The Therapeutics segment of the South Korea Nano Biotechnology Market encompasses a dynamic range of applications focused on enhancing patient outcomes through innovative treatments. Major players in the market are leveraging nanotechnology to develop cutting-edge Dental therapies, which significantly improve oral health by enabling targeted drug delivery and regenerative approaches.
Cardiac therapies are gaining traction as well, aimed at treating cardiovascular diseases through precise nanomedicine, thus enhancing drug efficacy and reducing side effects. Orthopedic therapies utilize nanotechnology for better implant integration and tissue regeneration, making surgical procedures more effective and reliable.
Additionally, the "Others" category addresses a variety of therapeutic applications, emphasizing the versatility and adaptability of nanotechnology in medicine.
The growth of the South Korea Nano Biotechnology Market is driven by increasing healthcare demands, advancements in research and development, and supportive government initiatives aimed at fostering innovation in the biotechnology space.
The overall trend indicates a growing focus on personalized medicine, significantly enhancing treatment efficacy in the Therapeutics segment and illustrating the potential for market expansion in coming years as these technologies mature.
South Korea Nano Biotechnology Market Key Players and Competitive Insights
The South Korea Nano Biotechnology Market is characterized by a dynamic landscape shaped by rapid technological advancements and an increasing emphasis on research and innovation. This sector focuses on leveraging nanotechnology in the fields of medicine, agriculture, and environmental science, offering various applications such as drug delivery systems, diagnostic tools, and therapeutic agents.
The heightened investment in biotechnology research and development by both public and private sectors in South Korea has fostered a conducive environment for growth and competition. Collaborations between universities and research institutions further enhance the market potential by driving forward innovative solutions and facilitating the commercialization of new technologies.
The ecosystem encourages the entrance of startups and established companies alike, each striving for a significant share of this burgeoning market.
Genexine stands as a prominent player within the South Korean Nano Biotechnology Market, distinguished by its innovative approach and advanced product pipeline. The company has a strong focus on developing novel therapeutics that harness the potential of nanobiotechnology to address unmet medical needs.
Genexine's robust research and development framework has enabled the creation of various products that aim to enhance drug efficacy and patient outcomes. Furthermore, its strategic collaborations with various stakeholders in the healthcare ecosystem have contributed to strengthening its market presence.
With a commitment to excellence and a reputation for pioneering breakthroughs, Genexine has established itself as a leading innovator, driving progress in the application of nanotechnology for biopharmaceuticals within South Korea.
Seegene is another key player in the South Korea Nano Biotechnology Market, gaining prominence through its innovative diagnostics platform that leverages nano-scale technologies. The company specializes in molecular diagnostics, offering a range of products that enable efficient detection of infectious diseases and genetic conditions.
Seegene's strong focus on rapid innovation has led to the development of proprietary technologies that significantly enhance the accuracy and speed of diagnostic testing. The company’s market presence is bolstered by its strategic partnerships and collaborations with regional and international research institutions, aiming to expand its product offerings and reach.
Seegene has also engaged in key mergers and acquisitions, further solidifying its position and increasing its technological capabilities in the market. Through its commitment to improving healthcare outcomes using cutting-edge biotechnology, Seegene continues to play a significant role in advancing the field of nano biotechnology within South Korea.
Key Companies in the South Korea Nano Biotechnology Market Include:
South Korea Nano Biotechnology Market Developments
Recent developments in the South Korea Nano Biotechnology Market have shown significant advancements, particularly with companies like Genexine, Seegene, Celltrion, and Hanmi Pharmaceutical leading in innovative therapies and diagnostics.
In September 2023, SK Biopharmaceuticals announced a partnership with LG Chem to collaborate on nano drug delivery systems, enhancing the capabilities within the sector. Furthermore, Samsung Biologics reported a surge in demand for biopharmaceutical manufacturing services, reflecting the growing size of the targeted therapies market.
In terms of mergers and acquisitions, in August 2023, Neuron Pharmaceuticals acquired a subsidiary of Piramal Pharma Solutions to expand its research capabilities in nano-based drug delivery.
The Korea Research Institute of Bioscience and Biotechnology continues to drive research initiatives and commercialization efforts, which are essential for advancing the nano-biotechnology landscape in the region.
Additionally, investments within the Osong Medical Innovation Foundation are boosting infrastructure for various biotechnology companies, contributing to a year-on-year market growth of about 12% as reported in late 2022.
This growth, alongside collaborations and innovations, significantly impacts the landscape of the South Korea Nano Biotechnology Market, turning it into a global player for cutting-edge biotechnological applications.
South Korea Nano Biotechnology Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 111.68(USD Million) |
| MARKET SIZE 2024 | 122.4(USD Million) |
| MARKET SIZE 2035 | 303.6(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.609% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Genexine, Seegene, Celltrion, Hanmi Pharmaceutical, Osong Medical Innovation Foundation, SK Biopharmaceuticals, LG Chem, Hankook Korus, Neuron Pharmaceuticals, Piramal Pharma Solutions, Korea Research Institute of Bioscience and Biotechnology, Samsung Biologics, Korea United Pharmaceutical, Medytox |
| SEGMENTS COVERED | Application, Therapeutics |
| KEY MARKET OPPORTUNITIES | Targeted drug delivery systems, Advanced cancer therapies, Nanomaterials for diagnostics, Sustainable agricultural solutions, Biocompatible implants and devices |
| KEY MARKET DYNAMICS | Rising investment in research, Increased demand for personalized medicine, Growing application in agriculture, Strong government support, Advancements in drug delivery systems |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Nano Biotechnology Market is expected to be valued at 122.4 million USD in 2024.
By 2035, the South Korea Nano Biotechnology Market is projected to reach a value of 303.6 million USD.
The expected CAGR for the South Korea Nano Biotechnology Market from 2025 to 2035 is 8.609 percent.
The applications of the South Korea Nano Biotechnology Market include Pharmaceuticals, Medical devices, Medical research, and Food and Agriculture.
The Pharmaceuticals segment is valued at 45.6 million USD in the South Korea Nano Biotechnology Market in 2024.
The Medical devices segment is forecasted to reach a value of 79.2 million USD by 2035.
Major players in this market include Genexine, Seegene, Celltrion, Hanmi Pharmaceutical, and SK Biopharmaceuticals, among others.
The Medical research segment is expected to be valued at 25.2 million USD in the South Korea Nano Biotechnology Market in 2024.
The Food and Agriculture segment is anticipated to grow to 50.4 million USD by 2035.
Growth drivers include advancements in technology, increasing demand for innovative medical solutions, and rising investments in biotechnological research.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
